French animal-health company Virbac has withdrawn its case at the EU courts against the European Commission’s approval for Zoetis’s Librela, an innovative osteoarthritis medicine for dogs.
Virbac alleged in the appeal that Zoetis was abusing its market power. The French company started the litigation in March 2021, seven months before the